OncoSec Medical Incorporated (ONCS) Stock Analyst Ratings
NASDAQ:ONCS - Nasdaq - US68234L4059 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 43% to ONCS. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 5.1. This target is 1739.83% above the current price.
ONCS was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about ONCS.
In the previous month the buy percentage consensus was at a similar level.
ONCS was analyzed by 6 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-11-14 | BTIG | Downgrade | Buy -> Neutral |
| 2021-03-08 | BTIG | Initiate | Buy |